Advanced IV Stem Cell Therapy
VitalGen International advances physical fitness and function in aging adults through intravenous stem cell therapy, within a physician-led, IRB-overseen clinical study.
What VitalGen does
We focus on intravenous infusion of culture-expanded human umbilical cord–derived mesenchymal stem cells (huc-MSC) — a non-surgical approach studied for its potential to support physical function and vitality as we age.
Intravenous infusion of culture-expanded huc-MSC — no surgery and no lengthy recovery time.
A Phase I–II, open-label, randomized, delayed-start pilot study conducted under IRB oversight.
A dedicated intake team handles scheduling, travel, and pre- and post-procedure data collection.
Where to go next
Understand the therapy, who is eligible, and how the study works.
The Science →Study overview, coordination support, and how to refer eligible patients.
For Providers →Meet Dr. Christopher J. Williams, Principal Investigator and Medical Director.
Our Physician →The Science · Patient Education
You are invited to learn about a Phase I–II clinical study evaluating the safety and efficacy of culture-expanded human umbilical cord–derived mesenchymal stem cells (huc-MSC) delivered intravenously to improve physical fitness and function in aging adults.
VitalGen IV Stem Cell Study — Patient Information Sheet. ICMS IRB# ICMS-2023-OUS-0701.
How the therapy works
IV stem cells represent a different path than traditional surgical regenerative procedures — bringing the benefits of advanced cell therapy without the pain and recovery time of surgery.
Our Physician
Principal Investigator & Medical Director, VitalGen IV Stem Cell Study
Dr. Williams is the founder and medical director of Interventional Orthopedics of Atlanta, Georgia's premier orthopedics practice. He is widely regarded as one of the world's leaders in advanced IV stem cell therapy.
When working with patients, he believes wholeheartedly in a holistic approach to medicine and takes pride in building a partnership with each patient, so they can learn the skills to achieve their functional goals in life.
Credentials & leadership
Leads the clinical program for VitalGen's IV stem cell study.
Georgia's premier orthopedics practice, pioneering interventional regenerative care.
Contributes to education and research in the field.
14 publications, 2 textbooks, and 10+ book chapters in regenerative medicine, with 15+ presentations on the world stage.
About VitalGen International
VitalGen International was founded to make advanced regenerative medicine accessible, responsible, and patient-centered. We coordinate intravenous stem cell therapy delivered within a rigorous, IRB-overseen clinical study — pairing scientific integrity with concierge-level care.
Designed to generate meaningful clinical data under ethical oversight.
Concierge support and coordination at every step of the journey.
Advancing the evidence base for regenerative medicine worldwide.
Leadership
Co-Founder & Managing Partner
Eric has held a range of healthcare executive roles, including overseeing the R&D team and patient-care operations of the founding Cayman clinic — patient recruitment, registry deployment, compliance, and staffing for IRB-approved studies. He brings 6+ years overseeing a regenerative medicine facility with the Cayman team, 9+ years operating regenerative medicine clinics, and 20+ years in value-based outpatient medicine. He holds a CAHME-accredited MBA in Healthcare Administration and is one of approximately 1,100 fellows of the ACMPE.
Co-Founder & Managing Partner
Lance has spent 25+ years in C-suite roles across healthcare, leading multi-level teams as administrator of a 60-physician internal medicine group, CEO of a 48-provider GI practice, COO of a 72-provider orthopaedic practice, and COO of a 144-provider multispecialty network. His expertise spans financial management, ancillary program expansion, strategic planning, and customer-service development. He served on the national MGMA board as Western Region chairman and as president of Colorado MGMA, and is one of approximately 1,100 fellows of the ACMPE.
For Referring Providers
You can play a vital role in advancing regenerative medicine. Refer your eligible patients to a Phase I–II clinical study evaluating the safety and efficacy of culture-expanded human umbilical cord–derived mesenchymal stem cells (huc-MSC) delivered intravenously.
Refer a patientHow you can participate
Why partner with us
Provider information sheet
VitalGen IV Stem Cell Study — Provider Information Sheet. ICMS IRB# ICMS-2023-OUS-0701.
Partner Clinic & Treatment Location
VitalGen International works alongside a trusted regenerative medicine clinic in Grand Cayman. Patients travel to the clinic for treatment in a single, coordinated visit.
The treatment site
Treatment takes place at an established regenerative medicine clinic in Grand Cayman. Patients receive joint injection therapy from the on-site clinical team, with VitalGen providing IV stem cell therapy alongside it.
For patients
Our concierge team walks you through eligibility, scheduling, travel to and from Grand Cayman, and the pre- and post-procedure data collection involved in the study.
Talk to our intake teamContact
Whether you're a patient exploring eligibility or a provider considering a referral, our concierge intake team will give you a personalized review.
The fastest way to reach our team is by email or phone. Send us a note with a bit about your situation, and we'll follow up with a personalized review of your eligibility.
Please include your name, the best phone number to reach you, and whether you're inquiring as a patient, a caregiver, or a referring provider.
Email us Call 877-588-7836